Source: The Patriot Light | AWK Network | VIEW ORIGINAL POST ==>
Moderna has halted its mRNA respiratory syncytial virus (RSV) vaccine trial for young children due to safety concerns.
“A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for respiratory syncytial virus (RSV) in infants is on hold over concerns about potential safety findings from a clinical trial involving two vaccine candidates,” the Center for Infectious Disease Research and Policy (CIDRAP) stated.
According to the document, a phase I trial of two experimental Moderna RSV vaccines for infants aged five to eight months was paused in July.
Reports stated five infants were hospitalized due to severe or very severe respiratory complications after receiving the experimental vaccine.
“The observed imbalance in severe/very severe cases of RSV LRTI in the mRNA-1345 and mRNA-1365 vaccine development program among 5-month to <8-month-old recipients of mRNA-1345>
MODERNA HALTS pediatric RSV trial after “at least…
8-month-old>
Read the full article here